Immatics (IMTX) Other Non Operating Income (2022 - 2025)
Immatics (IMTX) reported Other Non Operating Income of $150550.6 for Q2 2025, up 121.57% on a YoY basis from $67945.9 in Q2 2024, and down 91.04% sequentially from $1.7 million in Q1 2025.
Immatics (IMTX) Other Non Operating Income (2022 - 2025) Analysis & Trends
Immatics (IMTX) has 4 years of Other Non Operating Income data on file, last reported at $150550.6 in Q2 2025.
- For the quarter ending Q2 2025, Other Non Operating Income rose 121.57% year-over-year to $150550.6; the trailing twelve-month figure through Dec 2025 stood at $1.8 million (down 90.15% YoY), and the FY2025 full-year result was $2.0 million, down 89.54% from the prior year.
- Other Non Operating Income fell to $150550.6 in Q2 2025, from $1.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $18.5 million in Q1 2022 to a low of -$14.3 million in Q2 2023.
- A 4-year average of $2.2 million and a median of $1.4 million in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income tumbled 380.03% in 2023 and surged 377.2% in 2024, its largest moves.
- Tracing IMTX's Other Non Operating Income over 4 years: stood at $3.1 million in 2022, then soared by 72.69% to $5.4 million in 2023, then surged by 157.7% to $13.9 million in 2024, then sank by 98.92% to $150550.6 in 2025.
- Business Quant data shows IMTX's Other Non Operating Income at $150550.6 in Q2 2025, $1.7 million in Q1 2025, and $13.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 150,550.64 |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 13.93 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | -697,823.15 |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 5.41 Mn |
| Sep 30, 2023 | -1.52 Mn |
| Jun 30, 2023 | -14.27 Mn |
| Mar 31, 2023 | 7.94 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Sep 30, 2022 | -5.91 Mn |
| Jun 30, 2022 | -2.97 Mn |
| Mar 31, 2022 | 18.55 Mn |